This joint clinical practice guideline provides comprehensive recommendations for the diagnosis and management of stable ischemic heart disease.
Answers are grounded in this paper and cite their sources.
Guides current management of stable ischemic heart disease; extends prior guidelines for clinicians and future research.
DESCRIPTION: The American College of Physicians (ACP) developed this guideline with the American College of Cardiology Foundation (ACCF), American Heart Association (AHA), American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, and Society of Thoracic Surgeons to present the available evidence on the management of stable known or suspected ischemic heart disease. METHODS: Literature on this topic published before November 2011 was identified by using MEDLINE, Embase, Cochrane CENTRAL, PsychINFO, AMED, and SCOPUS. Searches were limited to human studies published in English. This guideline grades the evidence and recommendations according to a translation of the ACCF/AHA grading system into ACP's clinical practice guidelines grading system. RECOMMENDATIONS: The guideline includes 48 specific recommendations that address the following issues: patient education, management of proven risk factors (dyslipidemia, hypertension, diabetes, physical activity body weight, and smoking), risk factor reduction strategies of unproven benefit, medical therapy to prevent myocardial infarction and death and to relieve symptoms, alternative therapy, revascularization to improve survival and symptoms, and patient follow-up.
No takes yet. Share an insight, caveat, or question.
Amir Qaseem (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: